Christian Werner

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Essential role of interleukin-6 in post-stroke angiogenesis

Karen Gertz, Golo Kronenberg, Roland E. Kälin et al. · Brain · 2012 · 201 citations · Full text

Life Sciences, Neurology, Neuroscience +16

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

Gregory G. Schwartz, Vera A. Bittner, Patricio López‐Jaramillo et al. · Journal of the American College of Cardiology · 2021 · 141 citations · Full text

Medicine, Cardiology, Pharmacology +17

Prospective Assessment of Postoperative Pain After Craniotomy

Christine Mordhorst, Björn Latz, Thomas Kerz et al. · Journal of Neurosurgical Anesthesiology · 2010 · 133 citations

Medicine, Anesthesiology, Surgery +13

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 122 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17